Community/Retail

The American Medical Association and US Centers for Disease Control and Prevention have joined forces to take urgent action to Prevent Diabetes STAT.

Technology is creating new ways to help patients and health care providers evaluate medications, with both start-ups and the NIH looking to use smartphones to help with the process.

Actavis has launched the generic version of Fougera's clobetasol propionate cream 0.05% (Temovate)

A coalition of stakeholder organizations released a consensus document representing the medical, pharmacist, and supply chain spectrum highlighting the challenges and "red flag" warning signs related to prescribing and dispensing controlled substance prescriptions.

Regulators and stakeholders frequently debate the utility and effectiveness of OTC cough preparations.

US District Judge Lee Yeakel has entered a consent decree of permanent injunction between the United States and a Texas compounding pharmacy.

Hemoglobin recovery time following blood donation can be shortened with iron supplementation.

Many regulatory and professional organizations monitor hospitals for compliance to treatment guidelines, equating the use of evidence-based processes to high-quality care.

More than 300 pharmacy students, technicians, and pharmacists helped raise nearly $6500 at the 2015 Mid-Year Conference of the Pennsylvania Pharmacists Association.

Through the implementation of a bedside MTM program, we have experienced all of this, and much more. Read this article to see a real life example of a small community out-patient pharmacy working with a community hospital in the development of a quality transiton of care program.

One day, the standard thermometer may eventually be replaced by a device capable of so much more.

Pharmacists can play a vital role in patient education on poison prevention.

Employees at a Kroger pharmacy in Indiana were threatened with their lives during a robbery on March 4, 2015.

A University of Pittsburgh School of Pharmacy website is raising awareness of a growing heroin problem in its surrounding suburban and rural communities.

Compounding pharmacies across the nation face tighter regulations following the 2012 fungal meningitis outbreak from tainted drugs distributed by the New England Compounding Center.

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc, announced an agreement with the US Attorney's Office for the Eastern District of Pennsylvania and the US Department of Justice to resolve a previously disclosed government investigation relating to the manufacturing of certain OTC products at its Fort Washington, PA, facility.

All proposals related to Actavis' planned acquisition of Allergan were approved by both Actavis' and Allergan's shareholders.

Type 2 diabetes may be associated with impairments in cognitive abilities, such as working memory and verbal fluency.

The new journal, Scholarship of Teaching and Learning in Psychology, will feature evidence-based teaching tips and reviews of contemporary teaching theories in psychology.

The FDA today approved the first available treatment option for patients with high-risk neuroblastoma.

Pharmacist provider status would open up many opportunities for pharmacists in a variety of health care settings.

A review of the evidence and possible explanations.

The FDA has granted priority review to investigational cobimetinib in combination with vemurafenib (Zelboraf) in advanced melanoma.

In this podcast, Erin Albert, MBA, PharmD, JD, discusses the 7 present and future trends in pharmacy practice.

A second-year pharmacy student at Texas A&M Irma Lerma Rangel College of Pharmacy was incredulous when she learned she had been accepted into this summer's Mayo School of Health Sciences pharmacy internship program.

More than 2 years after a pharmacy in Sacramento, California, was robbed, a DNA match to the bloodstain left at the scene of the crime has led to an arrest.

Boehringer Ingelheim recently submitted a biologics license application to the FDA requesting accelerated approval of its investigational drug, idarucizumab, for the rapid reversal of anticoagulant effects of dabigatran (Pradaxa).

AWARxE is a free resource created by the National Association of Boards of Pharmacy to raise awareness on the dangers of prescription drug abuse.